PDE4A and chronic obstructive pulmonary disease: Roflumilast is a phosphodiesterase-4 inhibitors (PDE4), which has anti-inflammatory effects and can inhibit the release of inflammatory mediators, thus advantageously treating the respiratory diseases, such as pulmonary inflammation complicated by asthma and COPD [8].